Gene BRCC-3 and diagnostic and therapeutic uses thereof
US7442520B2 · kind B2 · utility
0Cited by
54References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 2003 |
| Grant date | Oct 28, 2008 |
| Priority date | — |
| Expiry date | Jun 18, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/136
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A gene that is a modulator of tumor growth and metastasis in certain cancer types is provided. This gene and corresponding polypeptide have diagnostic and therapeutic application for detecting and treating cancers that involve expression of BRCC-3 such as breast cancer and lung cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.